You are here

Cellular Biomedicine

J&J Makes $245M Play to Develop Next-Gen CAR-T Therapies

BioSpace

Tue, 05/2/23 - 11:46 am

Cellular Biomedicine

diffuse large B-cell lymphoma

A newly private Novartis partner bags a megaround on its first go to turbocharge CAR-T, cell therapy pipeline

Endpoints

Thu, 09/30/21 - 11:04 am

Cellular Biomedicine

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis

CP Wire

Fri, 03/16/18 - 11:17 am

Cellular Biomedicine

osteoarthritis of the knee

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis

Fri, 03/16/18 - 11:16 am

Cellular Biomedicine

The Winners And Losers Of JP Morgan Monday

Forbes

Mon, 01/8/18 - 10:23 pm

Cellular Biomedicine

Alder Biopharmaceuticals

PTC Therapeutics

Axovant Sciences

Oxford Immunotec